These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 27093299)

  • 1. Infantile Fibrosarcoma With NTRK3-ETV6 Fusion Successfully Treated With the Tropomyosin-Related Kinase Inhibitor LOXO-101.
    Nagasubramanian R; Wei J; Gordon P; Rastatter JC; Cox MC; Pappo A
    Pediatr Blood Cancer; 2016 Aug; 63(8):1468-70. PubMed ID: 27093299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A newborn with a large NTRK fusion positive infantile fibrosarcoma successfully treated with larotrectinib.
    Caldwell KJ; De La Cuesta E; Morin C; Pappo A; Helmig S
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28330. PubMed ID: 32452122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
    Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
    Ann Oncol; 2019 Nov; 30 Suppl 8():viii31-viii35. PubMed ID: 32223937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of Congenital Infantile Fibrosarcoma of the Bowel Presenting as a Neonatal Intussusception.
    Obayashi J; Koizumi H; Hoshikawa M; Wakisaka M; Fujikawa A; Kitagawa H; Takagi M
    Pathol Int; 2017 Dec; 67(12):644-648. PubMed ID: 29090505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation.
    Tognon C; Garnett M; Kenward E; Kay R; Morrison K; Sorensen PH
    Cancer Res; 2001 Dec; 61(24):8909-16. PubMed ID: 11751416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
    Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
    Ann Oncol; 2019 Nov; 30(Suppl_8):viii31-viii35. PubMed ID: 31738425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma.
    Kao YC; Fletcher CDM; Alaggio R; Wexler L; Zhang L; Sung YS; Orhan D; Chang WC; Swanson D; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2018 Jan; 42(1):28-38. PubMed ID: 28877062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group study.
    Gadd S; Beezhold P; Jennings L; George D; Leuer K; Huang CC; Huff V; Tognon C; Sorensen PH; Triche T; Coffin CM; Perlman EJ
    J Pathol; 2012 Sep; 228(1):119-30. PubMed ID: 22374738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of infantile fibrosarcoma associated to an abdominal aortic aneurysm with larotrectinib: a case report.
    Corral Sánchez MD; Galán Gómez V; Sastre Urgelles A; Plaza López de Sabando D; Rubio Aparicio P; Martínez Martínez L; Alonso Gamarra E; Pozo Kreilinger JJ; Regojo Zapata RM; López Gutiérrez JC; Antolín Alvarado E; Gómez Martín F; Sánchez Torres AM; Marín Manzano E; González Del Valle L; Pérez-Martínez A
    Pediatr Hematol Oncol; 2021 Aug; 38(5):504-509. PubMed ID: 33622165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors.
    Bourgeois JM; Knezevich SR; Mathers JA; Sorensen PH
    Am J Surg Pathol; 2000 Jul; 24(7):937-46. PubMed ID: 10895816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma-like mesenchymal tumors.
    Motta M; Barresi S; Pizzi S; Bifano D; Lopez Marti J; Garrido-Pontnou M; Flex E; Bruselles A; Giovannoni I; Rotundo G; Fragale A; Tirelli V; Vallese S; Ciolfi A; Bisogno G; Alaggio R; Tartaglia M
    J Pathol; 2024 Jun; 263(2):166-177. PubMed ID: 38629245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital-infantile fibrosarcoma. A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues.
    Sheng WQ; Hisaoka M; Okamoto S; Tanaka A; Meis-Kindblom JM; Kindblom LG; Ishida T; Nojima T; Hashimoto H
    Am J Clin Pathol; 2001 Mar; 115(3):348-55. PubMed ID: 11242790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infantile fibrosarcoma of thigh--a case report.
    Himori K; Hatori M; Watanabe M; Moriya T; Ogose A; Hashimoto H; Kokubun S
    Ups J Med Sci; 2005; 110(1):85-93. PubMed ID: 15801689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second Report of
    Hughes CE; Correa H; Benedetti DJ; Smith B; Sumegi J; Bridge J
    Pediatr Dev Pathol; 2021; 24(6):554-558. PubMed ID: 34120511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma.
    Knezevich SR; McFadden DE; Tao W; Lim JF; Sorensen PH
    Nat Genet; 1998 Feb; 18(2):184-7. PubMed ID: 9462753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy.
    McCahon E; Sorensen PH; Davis JH; Rogers PC; Schultz KR
    Med Pediatr Oncol; 2003 May; 40(5):288-92. PubMed ID: 12652616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infantile fibrosarcoma-like tumor driven by novel
    Gupta A; Belsky JA; Schieffer KM; Leraas K; Varga E; McGrath SD; Koo SC; Magrini V; Wilson RK; White P; Mardis ER; Jatana KR; Cottrell CE; Setty BA
    Cold Spring Harb Mol Case Stud; 2020 Oct; 6(5):. PubMed ID: 33028644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma.
    Rubin BP; Chen CJ; Morgan TW; Xiao S; Grier HE; Kozakewich HP; Perez-Atayde AR; Fletcher JA
    Am J Pathol; 1998 Nov; 153(5):1451-8. PubMed ID: 9811336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours.
    Yamamoto H; Yoshida A; Taguchi K; Kohashi K; Hatanaka Y; Yamashita A; Mori D; Oda Y
    Histopathology; 2016 Jul; 69(1):72-83. PubMed ID: 26647767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
    Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH
    Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.